Bio-Rad Laboratories, Inc.

DB:BUWA Stock Report

Market Cap: €5.6b

Bio-Rad Laboratories Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:BUWA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Sep 24Sell€144,347James BarryIndividual484€298.24
13 Jun 24Sell€96,638Michael CrowleyIndividual369€261.89

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BUWA?
Owner TypeNumber of SharesOwnership Percentage
State or Government17,4600.0605%
Private Companies4,060,05414.1%
Individual Insiders4,489,91215.6%
Institutions20,294,75770.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 85.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Blue Raven Partners, L.P.
4,060,054€835.0m0%no data
11.8%
Alice Schwartz
3,209,438€660.1m0%no data
8.43%
First Eagle Investment Management, LLC
2,294,261€471.8m46.5%0.68%
7.43%
BlackRock, Inc.
2,021,714€415.8m0.5%0.01%
7.03%
The Vanguard Group, Inc.
1,912,157€393.3m-0.4%0.01%
4.46%
Norman Schwartz
1,214,594€249.8m0%no data
3.36%
Veritas Asset Management LLP
913,122€187.8m-6.52%1.33%
3.22%
Dimensional Fund Advisors LP
877,040€180.4m17.6%0.03%
2.66%
Ariel Investments, LLC
724,660€149.0m29.3%1.94%
2.55%
State Street Global Advisors, Inc.
694,520€142.8m0.63%0.01%
2.21%
UBS Asset Management AG
600,444€123.5m28.3%0.01%
2.2%
EARNEST Partners, LLC
599,621€123.3m-2.98%0.66%
2.19%
Van Eck Associates Corporation
596,730€122.7m-17.5%0.14%
1.43%
Managed Account Advisors LLC
389,314€80.1m-5.23%0.02%
1.37%
First Pacific Advisors, LP
372,555€76.6m136%1.02%
1.26%
Geode Capital Management, LLC
342,943€70.5m6.51%0.01%
1.25%
Millennium Management LLC
339,061€69.7m-11.3%0.07%
1.19%
Southeastern Asset Management, Inc.
323,805€66.6m4.97%2.88%
1.17%
Parnassus Investments, LLC
318,111€65.4m2.33%0.18%
1.08%
Mawer Investment Management Ltd.
294,879€60.6m14.8%0.17%
1.03%
Thompson, Siegel & Walmsley LLC
279,489€57.5m8.26%0.82%
0.97%
Select Equity Group, L.P.
265,180€54.5m-42.4%0.25%
0.96%
Northern Trust Global Investments
261,122€53.7m0.1%0.01%
0.93%
SEI Investments Company
253,562€52.1m-6.57%0.08%
0.83%
Deerfield Management Company, L.P. Series C
226,070€46.5m49.1%1.15%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 13:55
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio-Rad Laboratories, Inc. is covered by 25 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Jon WoodBofA Global Research
Sel HardyCFRA Equity Research